U.K. Pharmaceutical Analytical Testing Outsourcing Market Size & Outlook
The pharmaceutical analytical testing outsourcing market in the UK is expected to reach a projected revenue of US$ 965.5 million by 2033. A compound annual growth rate of 10.2% is expected of the UK pharmaceutical analytical testing outsourcing market from 2026 to 2033.
UK pharmaceutical analytical testing outsourcing market highlights
The UK pharmaceutical analytical testing outsourcing market generated a revenue of USD 442.8 million in 2025 and is expected to reach USD 965.5 million by 2033.
The UK market is expected to grow at a CAGR of 10.2% from 2026 to 2033.
In terms of segment, bioanalytical testing was the largest revenue generating service in 2025.
Other Testing Services is the most lucrative service segment registering the fastest growth during the forecast period.
Pharmaceutical analytical testing outsourcing market data book summary
Market revenue in 2025
USD 442.8 million
Market revenue in 2033
USD 965.5 million
Growth rate
10.2% (CAGR from 2026 to 2033)
Largest segment
Bioanalytical testing
Fastest growing segment
Other Testing Services
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Bioanalytical Testing, Method Development and Validation, Stability Testing, Other Testing Services
Key market players worldwide
SGS AG, LabCorp, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, PPD, Wuxi AppTec Co Ltd, Boston Analytical, Charles River Laboratories International Inc, West Pharmaceutical Services Inc
Other key industry trends
In terms of revenue, UK accounted for 4.6% of the global pharmaceutical analytical testing outsourcing market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK pharmaceutical analytical testing outsourcing market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 965.5 million by 2033.
U.K. Pharmaceutical Analytical Testing Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Analytical Testing Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Bioanalytical Testing was the largest segment with a revenue share of 42.82% in 2025.
Horizon Databook has segmented the U.K. pharmaceutical analytical testing outsourcing market based on bioanalytical testing, method development and validation, stability testing, other testing services covering the revenue growth of each sub-segment from 2021 to 2033.
U.K. Pharmaceutical Analytical Testing Outsourcing Market Service Outlook (Revenue, USD Million , 2021-2033)
Bioanalytical Testing
Method Development and Validation
Stability Testing
Other Testing Services
U.K. Pharmaceutical Analytical Testing Outsourcing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical Companies
Biopharmaceutical Companies
Others
Reasons to subscribe to Pharmaceutical Analytical Testing Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pharmaceutical Analytical Testing Outsourcing Market Outlook databook
Our clientele includes a mix of Pharmaceutical Analytical Testing Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Pharmaceutical Analytical Testing Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Pharmaceutical Analytical Testing Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.